Rank | Gene Set | Z-score |
---|---|---|
1 | skeletal muscle fiber development (GO:0048741) | 8.76589882 |
2 | * actin filament-based movement (GO:0030048) | 7.91702091 |
3 | plasma membrane repair (GO:0001778) | 7.54606464 |
4 | myotube cell development (GO:0014904) | 7.49421598 |
5 | skeletal muscle tissue regeneration (GO:0043403) | 6.86860385 |
6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.82995740 |
7 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.61903502 |
8 | sarcomere organization (GO:0045214) | 6.53668107 |
9 | * striated muscle contraction (GO:0006941) | 6.50935388 |
10 | glycogen catabolic process (GO:0005980) | 6.47356700 |
11 | creatine metabolic process (GO:0006600) | 6.37424304 |
12 | striated muscle atrophy (GO:0014891) | 6.10157970 |
13 | glucan catabolic process (GO:0009251) | 6.06094057 |
14 | purine nucleotide salvage (GO:0032261) | 5.91325685 |
15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.88729193 |
16 | myofibril assembly (GO:0030239) | 5.82750077 |
17 | response to inactivity (GO:0014854) | 5.76876178 |
18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.70601992 |
19 | response to muscle activity (GO:0014850) | 5.68239824 |
20 | cellular polysaccharide catabolic process (GO:0044247) | 5.63742372 |
21 | * muscle contraction (GO:0006936) | 5.63170777 |
22 | cytidine metabolic process (GO:0046087) | 5.62605866 |
23 | cytidine catabolic process (GO:0006216) | 5.62605866 |
24 | cytidine deamination (GO:0009972) | 5.62605866 |
25 | carnitine shuttle (GO:0006853) | 5.58612175 |
26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.56830515 |
27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.50088622 |
28 | polysaccharide catabolic process (GO:0000272) | 5.44239477 |
29 | muscle atrophy (GO:0014889) | 5.29059061 |
30 | striated muscle adaptation (GO:0014888) | 5.27320901 |
31 | muscle fiber development (GO:0048747) | 5.19154232 |
32 | glucan biosynthetic process (GO:0009250) | 5.06479827 |
33 | glycogen biosynthetic process (GO:0005978) | 5.06479827 |
34 | * muscle system process (GO:0003012) | 5.00427328 |
35 | IMP metabolic process (GO:0046040) | 4.95251599 |
36 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.86181796 |
37 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.77249397 |
38 | fatty acid transmembrane transport (GO:1902001) | 4.72191136 |
39 | actomyosin structure organization (GO:0031032) | 4.66169827 |
40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.42614422 |
41 | glycogen metabolic process (GO:0005977) | 4.39629492 |
42 | NADH metabolic process (GO:0006734) | 4.38597041 |
43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.38401050 |
44 | cardiac muscle hypertrophy (GO:0003300) | 4.35918748 |
45 | glucan metabolic process (GO:0044042) | 4.30812747 |
46 | cellular glucan metabolic process (GO:0006073) | 4.30812747 |
47 | muscle adaptation (GO:0043500) | 4.26459166 |
48 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.21166627 |
49 | negative regulation of muscle hypertrophy (GO:0014741) | 4.17300253 |
50 | striated muscle hypertrophy (GO:0014897) | 4.15916402 |
51 | carnitine transmembrane transport (GO:1902603) | 4.13502672 |
52 | muscle organ development (GO:0007517) | 4.06085721 |
53 | muscle cell cellular homeostasis (GO:0046716) | 4.05694688 |
54 | regulation of relaxation of muscle (GO:1901077) | 4.00640093 |
55 | muscle structure development (GO:0061061) | 4.00230328 |
56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.98412723 |
57 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.98292332 |
58 | response to activity (GO:0014823) | 3.89693116 |
59 | myotube differentiation (GO:0014902) | 3.89692387 |
60 | fructose metabolic process (GO:0006000) | 3.88793713 |
61 | cardiac muscle contraction (GO:0060048) | 3.87144506 |
62 | neuronal action potential propagation (GO:0019227) | 3.85750444 |
63 | skeletal muscle tissue development (GO:0007519) | 3.83351531 |
64 | neuromuscular synaptic transmission (GO:0007274) | 3.83197320 |
65 | IMP biosynthetic process (GO:0006188) | 3.82687098 |
66 | striated muscle cell development (GO:0055002) | 3.82214867 |
67 | muscle organ morphogenesis (GO:0048644) | 3.80393129 |
68 | muscle tissue morphogenesis (GO:0060415) | 3.80272049 |
69 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.77945786 |
70 | carnitine transport (GO:0015879) | 3.76938130 |
71 | amino-acid betaine transport (GO:0015838) | 3.76938130 |
72 | muscle hypertrophy (GO:0014896) | 3.75952323 |
73 | positive regulation of myotube differentiation (GO:0010831) | 3.69879330 |
74 | myoblast fusion (GO:0007520) | 3.67676375 |
75 | cellular response to dexamethasone stimulus (GO:0071549) | 3.67619033 |
76 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.64093124 |
77 | striated muscle tissue development (GO:0014706) | 3.63168565 |
78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.60372615 |
79 | gluconeogenesis (GO:0006094) | 3.59482329 |
80 | * regulation of striated muscle contraction (GO:0006942) | 3.59372011 |
81 | regulation of coenzyme metabolic process (GO:0051196) | 3.58384810 |
82 | regulation of cofactor metabolic process (GO:0051193) | 3.58384810 |
83 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.57215442 |
84 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.57215442 |
85 | cellular carbohydrate catabolic process (GO:0044275) | 3.55404418 |
86 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53689711 |
87 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.52031934 |
88 | negative regulation of protein localization to cell surface (GO:2000009) | 3.51610930 |
89 | cardiac muscle cell development (GO:0055013) | 3.47134135 |
90 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44146017 |
91 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44146017 |
92 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.43655652 |
93 | response to dexamethasone (GO:0071548) | 3.42356751 |
94 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.41207147 |
95 | regulation of myotube differentiation (GO:0010830) | 3.35671372 |
96 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.34521439 |
97 | positive regulation of myoblast differentiation (GO:0045663) | 3.32844526 |
98 | syncytium formation (GO:0006949) | 3.32536242 |
99 | regulation of sarcomere organization (GO:0060297) | 3.32379272 |
100 | adult heart development (GO:0007512) | 3.32246190 |
101 | muscle cell fate commitment (GO:0042693) | 3.30615663 |
102 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.28731365 |
103 | muscle cell development (GO:0055001) | 3.26531784 |
104 | negative regulation of muscle contraction (GO:0045932) | 3.26303217 |
105 | cardiac cell development (GO:0055006) | 3.23826355 |
106 | regulation of myoblast differentiation (GO:0045661) | 3.21739956 |
107 | heart contraction (GO:0060047) | 3.20590995 |
108 | regulation of skeletal muscle fiber development (GO:0048742) | 3.20079970 |
109 | neuromuscular junction development (GO:0007528) | 3.19837298 |
110 | hexose biosynthetic process (GO:0019319) | 3.19631086 |
111 | muscle tissue development (GO:0060537) | 3.18204030 |
112 | tricarboxylic acid cycle (GO:0006099) | 3.17194742 |
113 | cardiac muscle adaptation (GO:0014887) | 3.16870944 |
114 | muscle hypertrophy in response to stress (GO:0003299) | 3.16870944 |
115 | cellular polysaccharide metabolic process (GO:0044264) | 3.09134987 |
116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.06018358 |
117 | cardiac myofibril assembly (GO:0055003) | 3.05099158 |
118 | regulation of actin filament-based movement (GO:1903115) | 3.03884979 |
119 | skeletal muscle cell differentiation (GO:0035914) | 3.03315934 |
120 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.02218404 |
121 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.01644975 |
122 | heart process (GO:0003015) | 3.01563827 |
123 | * muscle filament sliding (GO:0030049) | 13.0402910 |
124 | * actin-myosin filament sliding (GO:0033275) | 13.0402910 |
125 | regulation of skeletal muscle contraction (GO:0014819) | 12.7665402 |
126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.7848196 |
127 | * skeletal muscle contraction (GO:0003009) | 10.7820982 |
128 | * actin-mediated cell contraction (GO:0070252) | 10.6299558 |
129 | skeletal muscle adaptation (GO:0043501) | 10.0535470 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.26421687 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.32526309 |
3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.42235823 |
4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.40487258 |
5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18206727 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.12950220 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.69151831 |
8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.52007142 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46780078 |
10 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.38584677 |
11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.38584677 |
12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.36163568 |
13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.15433862 |
14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04795379 |
15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04170383 |
16 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.99234705 |
17 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.92325794 |
18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89170112 |
19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83791800 |
20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.78854853 |
21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76638603 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73917182 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72431508 |
24 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71098542 |
25 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.66825656 |
26 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.65974634 |
27 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.62667018 |
28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59130555 |
29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.58252025 |
30 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.57055089 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55560653 |
32 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51555555 |
33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46617132 |
34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43100029 |
35 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.39654790 |
36 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.39614142 |
37 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.38685406 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37675978 |
39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34636044 |
40 | SA1_27219007_Chip-Seq_Bcells_Human | 1.33955658 |
41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32691756 |
42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28162115 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26207626 |
44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25701769 |
45 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.24040775 |
46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22828606 |
47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22515376 |
48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21322586 |
49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.21102311 |
50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.20862660 |
51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20275179 |
52 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18706386 |
53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16684925 |
54 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.16345375 |
55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16295526 |
56 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13831594 |
57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13392064 |
58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10067779 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09305308 |
60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09213338 |
61 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06983767 |
62 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06829762 |
63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06652281 |
64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06590296 |
65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06590296 |
66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06285939 |
67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05560838 |
68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05191904 |
69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05116512 |
70 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04981133 |
71 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04015118 |
72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03333159 |
73 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02896252 |
74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02679515 |
75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01884582 |
76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01745277 |
77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01448288 |
78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01231313 |
79 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01170500 |
80 | P68_20966046_ChIP-Seq_HELA_Human | 1.01119780 |
81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00665953 |
82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00583074 |
83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00482414 |
84 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00217217 |
85 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.00186130 |
86 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99963232 |
87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99757854 |
88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98439097 |
89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98341028 |
90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96993810 |
91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96777957 |
92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96291667 |
93 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95860151 |
94 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95296570 |
95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95061646 |
96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94968078 |
97 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.94755742 |
98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94544887 |
99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93454812 |
100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.93066475 |
101 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93031433 |
102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92318327 |
103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91779509 |
104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91457995 |
105 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91395824 |
106 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89996623 |
107 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89966771 |
108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89678947 |
109 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.89103420 |
110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88670285 |
111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88576252 |
112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88461537 |
113 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87534226 |
114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87244135 |
115 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86255797 |
116 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86255797 |
117 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.86012614 |
118 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.85394390 |
119 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.85255664 |
120 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84627593 |
121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84076045 |
122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83464520 |
123 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83378972 |
124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83267039 |
125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83242972 |
126 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.82250637 |
127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81699283 |
128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80921964 |
129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80921964 |
130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80262210 |
131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80091571 |
132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79831178 |
133 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78506417 |
134 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74397110 |
135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74234562 |
136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73535710 |
137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73127517 |
138 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.72440605 |
139 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.72067213 |
140 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.70790210 |
141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70040333 |
142 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.69746814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 8.04824233 |
2 | MP0000749_muscle_degeneration | 6.53082048 |
3 | MP0003646_muscle_fatigue | 5.94050288 |
4 | MP0000751_myopathy | 5.69878425 |
5 | MP0000747_muscle_weakness | 4.62491543 |
6 | MP0002106_abnormal_muscle_physiology | 4.26899740 |
7 | MP0004036_abnormal_muscle_relaxation | 3.91123920 |
8 | MP0000759_abnormal_skeletal_muscle | 3.88903382 |
9 | MP0005369_muscle_phenotype | 3.58559422 |
10 | MP0002269_muscular_atrophy | 3.52340733 |
11 | MP0004087_abnormal_muscle_fiber | 3.45241672 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 3.35655391 |
13 | MP0000750_abnormal_muscle_regeneration | 3.28287343 |
14 | MP0004130_abnormal_muscle_cell | 3.20568002 |
15 | MP0005620_abnormal_muscle_contractility | 3.11429148 |
16 | MP0000733_abnormal_muscle_development | 2.61419314 |
17 | MP0004233_abnormal_muscle_weight | 2.52997774 |
18 | MP0002108_abnormal_muscle_morphology | 2.20662958 |
19 | MP0002332_abnormal_exercise_endurance | 2.11638079 |
20 | MP0005330_cardiomyopathy | 1.85293957 |
21 | MP0006036_abnormal_mitochondrial_physio | 1.75604157 |
22 | MP0004185_abnormal_adipocyte_glucose | 1.74978836 |
23 | MP0005275_abnormal_skin_tensile | 1.63239846 |
24 | MP0004084_abnormal_cardiac_muscle | 1.56222494 |
25 | MP0004270_analgesia | 1.51976462 |
26 | MP0002971_abnormal_brown_adipose | 1.44636454 |
27 | MP0005666_abnormal_adipose_tissue | 1.35852303 |
28 | MP0000013_abnormal_adipose_tissue | 1.34089851 |
29 | MP0002972_abnormal_cardiac_muscle | 1.24849126 |
30 | MP0004215_abnormal_myocardial_fiber | 1.22912037 |
31 | MP0004484_altered_response_of | 1.21627154 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.18204460 |
33 | MP0003950_abnormal_plasma_membrane | 1.15070226 |
34 | MP0010630_abnormal_cardiac_muscle | 1.14641095 |
35 | MP0005375_adipose_tissue_phenotype | 1.08567129 |
36 | MP0003806_abnormal_nucleotide_metabolis | 1.02161627 |
37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01168450 |
38 | MP0001661_extended_life_span | 0.97008825 |
39 | MP0002822_catalepsy | 0.96101642 |
40 | MP0005266_abnormal_metabolism | 0.95547667 |
41 | MP0004134_abnormal_chest_morphology | 0.94547939 |
42 | MP0006035_abnormal_mitochondrial_morpho | 0.87587963 |
43 | MP0002234_abnormal_pharynx_morphology | 0.83825067 |
44 | MP0002796_impaired_skin_barrier | 0.81499448 |
45 | MP0000762_abnormal_tongue_morphology | 0.81284764 |
46 | MP0001544_abnormal_cardiovascular_syste | 0.77676524 |
47 | MP0005385_cardiovascular_system_phenoty | 0.77676524 |
48 | MP0009250_abnormal_appendicular_skeleto | 0.76280772 |
49 | MP0000372_irregular_coat_pigmentation | 0.76269349 |
50 | MP0009780_abnormal_chondrocyte_physiolo | 0.74303147 |
51 | MP0001299_abnormal_eye_distance/ | 0.73832275 |
52 | MP0003828_pulmonary_edema | 0.72327408 |
53 | MP0000003_abnormal_adipose_tissue | 0.69512021 |
54 | MP0003656_abnormal_erythrocyte_physiolo | 0.68974710 |
55 | MP0000579_abnormal_nail_morphology | 0.65864986 |
56 | MP0004085_abnormal_heartbeat | 0.65657456 |
57 | MP0004147_increased_porphyrin_level | 0.64842268 |
58 | MP0008961_abnormal_basal_metabolism | 0.64756774 |
59 | MP0003137_abnormal_impulse_conducting | 0.61058144 |
60 | MP0003879_abnormal_hair_cell | 0.60372471 |
61 | MP0005503_abnormal_tendon_morphology | 0.59562927 |
62 | MP0010030_abnormal_orbit_morphology | 0.59058481 |
63 | MP0005334_abnormal_fat_pad | 0.57951159 |
64 | MP0002078_abnormal_glucose_homeostasis | 0.53651413 |
65 | MP0004043_abnormal_pH_regulation | 0.53594430 |
66 | MP0008438_abnormal_cutaneous_collagen | 0.53292581 |
67 | MP0000383_abnormal_hair_follicle | 0.52197671 |
68 | MP0005670_abnormal_white_adipose | 0.50346499 |
69 | MP0001243_abnormal_dermal_layer | 0.48548028 |
70 | MP0000266_abnormal_heart_morphology | 0.48424209 |
71 | MP0002896_abnormal_bone_mineralization | 0.47764558 |
72 | MP0002089_abnormal_postnatal_growth/wei | 0.47514456 |
73 | MP0000343_altered_response_to | 0.46940156 |
74 | MP0003045_fibrosis | 0.46652767 |
75 | MP0005452_abnormal_adipose_tissue | 0.45032147 |
76 | MP0008775_abnormal_heart_ventricle | 0.44472925 |
77 | MP0002127_abnormal_cardiovascular_syste | 0.42619387 |
78 | MP0008569_lethality_at_weaning | 0.42237090 |
79 | MP0003959_abnormal_lean_body | 0.42064346 |
80 | MP0002734_abnormal_mechanical_nocicepti | 0.41661885 |
81 | MP0009672_abnormal_birth_weight | 0.41420359 |
82 | MP0001346_abnormal_lacrimal_gland | 0.41220664 |
83 | MP0002249_abnormal_larynx_morphology | 0.40491577 |
84 | MP0005501_abnormal_skin_physiology | 0.39992771 |
85 | MP0005083_abnormal_biliary_tract | 0.39030153 |
86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38889502 |
87 | MP0002114_abnormal_axial_skeleton | 0.38527463 |
88 | MP0001849_ear_inflammation | 0.37340266 |
89 | MP0006276_abnormal_autonomic_nervous | 0.35284572 |
90 | MP0002060_abnormal_skin_morphology | 0.34922850 |
91 | MP0000427_abnormal_hair_cycle | 0.34234331 |
92 | MP0006138_congestive_heart_failure | 0.33271256 |
93 | MP0010678_abnormal_skin_adnexa | 0.32738436 |
94 | MP0005376_homeostasis/metabolism_phenot | 0.30801690 |
95 | MP0009115_abnormal_fat_cell | 0.30748446 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.30669029 |
97 | MP0003948_abnormal_gas_homeostasis | 0.30537321 |
98 | MP0004510_myositis | 0.30000645 |
99 | MP0005535_abnormal_body_temperature | 0.29782676 |
100 | MP0004142_abnormal_muscle_tone | 0.28709846 |
101 | MP0005319_abnormal_enzyme/_coenzyme | 0.28696181 |
102 | MP0000377_abnormal_hair_follicle | 0.27835429 |
103 | MP0002638_abnormal_pupillary_reflex | 0.27564504 |
104 | MP0005165_increased_susceptibility_to | 0.26837043 |
105 | MP0001943_abnormal_respiration | 0.24063754 |
106 | MP0003385_abnormal_body_wall | 0.22929408 |
107 | MP0000534_abnormal_ureter_morphology | 0.22204245 |
108 | MP0004858_abnormal_nervous_system | 0.22030104 |
109 | MP0005451_abnormal_body_composition | 0.21712377 |
110 | MP0008770_decreased_survivor_rate | 0.21096592 |
111 | MP0000230_abnormal_systemic_arterial | 0.20674247 |
112 | MP0003755_abnormal_palate_morphology | 0.20429233 |
113 | MP0005166_decreased_susceptibility_to | 0.20103148 |
114 | MP0009931_abnormal_skin_appearance | 0.19963593 |
115 | MP0002128_abnormal_blood_circulation | 0.19281797 |
116 | MP0004197_abnormal_fetal_growth/weight/ | 0.19278974 |
117 | MP0002932_abnormal_joint_morphology | 0.19116829 |
118 | MP0005076_abnormal_cell_differentiation | 0.18989623 |
119 | MP0002066_abnormal_motor_capabilities/c | 0.17415426 |
120 | MP0005423_abnormal_somatic_nervous | 0.17361504 |
121 | MP0001542_abnormal_bone_strength | 0.15629885 |
122 | MP0005187_abnormal_penis_morphology | 0.14352968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 9.73432165 |
2 | Exercise-induced myalgia (HP:0003738) | 8.70246430 |
3 | Type 1 muscle fiber predominance (HP:0003803) | 8.10746995 |
4 | Exercise-induced muscle cramps (HP:0003710) | 7.86703938 |
5 | Myopathic facies (HP:0002058) | 7.18349692 |
6 | * Distal arthrogryposis (HP:0005684) | 6.96182002 |
7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.77620432 |
8 | Calf muscle hypertrophy (HP:0008981) | 6.03484019 |
9 | Difficulty running (HP:0009046) | 5.45531981 |
10 | Muscle fiber splitting (HP:0003555) | 5.31937752 |
11 | Myoglobinuria (HP:0002913) | 5.08417004 |
12 | * Round ear (HP:0100830) | 5.06789513 |
13 | Hyporeflexia of lower limbs (HP:0002600) | 4.99515703 |
14 | * Ulnar deviation of the wrist (HP:0003049) | 4.89760065 |
15 | EMG: myopathic abnormalities (HP:0003458) | 4.66769784 |
16 | Muscle stiffness (HP:0003552) | 4.65241092 |
17 | Increased connective tissue (HP:0009025) | 4.55531188 |
18 | Rhabdomyolysis (HP:0003201) | 4.26763694 |
19 | Abnormality of the calf musculature (HP:0001430) | 4.15632752 |
20 | * Calcaneovalgus deformity (HP:0001848) | 4.15436243 |
21 | * Absent phalangeal crease (HP:0006109) | 4.11208231 |
22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.10352359 |
23 | Myotonia (HP:0002486) | 4.08840102 |
24 | Malignant hyperthermia (HP:0002047) | 3.96058048 |
25 | * Deformed tarsal bones (HP:0008119) | 3.93760872 |
26 | Neck muscle weakness (HP:0000467) | 3.76750201 |
27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.61104117 |
28 | Frequent falls (HP:0002359) | 3.53517518 |
29 | Subaortic stenosis (HP:0001682) | 3.52544050 |
30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.52544050 |
31 | Rimmed vacuoles (HP:0003805) | 3.50699471 |
32 | Difficulty climbing stairs (HP:0003551) | 3.42201732 |
33 | * Abnormal finger flexion creases (HP:0006143) | 3.36687702 |
34 | Pelvic girdle muscle weakness (HP:0003749) | 3.21232077 |
35 | Shoulder girdle muscle weakness (HP:0003547) | 3.20770128 |
36 | Areflexia of lower limbs (HP:0002522) | 3.17148006 |
37 | Popliteal pterygium (HP:0009756) | 3.12272278 |
38 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.10048374 |
39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.10048374 |
40 | Slender build (HP:0001533) | 3.09123693 |
41 | Fatigable weakness (HP:0003473) | 2.97343710 |
42 | Abnormality of the neuromuscular junction (HP:0003398) | 2.97343710 |
43 | Hyperkalemia (HP:0002153) | 2.93996382 |
44 | Asymmetric septal hypertrophy (HP:0001670) | 2.80356615 |
45 | EMG: neuropathic changes (HP:0003445) | 2.66934084 |
46 | Distal lower limb muscle weakness (HP:0009053) | 2.65816700 |
47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.63488290 |
48 | Sudden death (HP:0001699) | 2.62707896 |
49 | Bundle branch block (HP:0011710) | 2.61167544 |
50 | Paralysis (HP:0003470) | 2.55824973 |
51 | Bulbar palsy (HP:0001283) | 2.55580726 |
52 | Fetal akinesia sequence (HP:0001989) | 2.51106548 |
53 | Generalized muscle weakness (HP:0003324) | 2.45625323 |
54 | Spinal rigidity (HP:0003306) | 2.42360678 |
55 | Muscular dystrophy (HP:0003560) | 2.37342721 |
56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.34733643 |
57 | * Abnormality of the calcaneus (HP:0008364) | 2.33137034 |
58 | Gowers sign (HP:0003391) | 2.30692698 |
59 | Weak cry (HP:0001612) | 2.26405175 |
60 | Abnormality of placental membranes (HP:0011409) | 2.26323192 |
61 | Amniotic constriction ring (HP:0009775) | 2.26323192 |
62 | Nonprogressive disorder (HP:0003680) | 2.26089807 |
63 | Proximal amyotrophy (HP:0007126) | 2.24694676 |
64 | Limb-girdle muscle weakness (HP:0003325) | 2.24677593 |
65 | Hypoplastic ischia (HP:0003175) | 2.24495907 |
66 | Scapular winging (HP:0003691) | 2.22548000 |
67 | Facial diplegia (HP:0001349) | 2.21545389 |
68 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.14367472 |
69 | Limb-girdle muscle atrophy (HP:0003797) | 2.07508071 |
70 | Distal lower limb amyotrophy (HP:0008944) | 2.04047987 |
71 | Breech presentation (HP:0001623) | 2.00707633 |
72 | Muscle fiber inclusion bodies (HP:0100299) | 10.4822593 |
73 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.1693388 |
74 | Abnormality of the ischium (HP:0003174) | 1.96082645 |
75 | Waddling gait (HP:0002515) | 1.94840816 |
76 | Progressive muscle weakness (HP:0003323) | 1.93578529 |
77 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92351349 |
78 | Hip contracture (HP:0003273) | 1.87300977 |
79 | Abnormality of the foot musculature (HP:0001436) | 1.85997030 |
80 | Achilles tendon contracture (HP:0001771) | 1.84639047 |
81 | Aplasia of the musculature (HP:0100854) | 1.83832331 |
82 | Limited hip movement (HP:0008800) | 1.81612918 |
83 | * Ulnar deviation of finger (HP:0009465) | 1.72576677 |
84 | Trismus (HP:0000211) | 1.70630666 |
85 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.70399383 |
86 | Heart block (HP:0012722) | 1.69682920 |
87 | Abnormality of the Achilles tendon (HP:0005109) | 1.67622846 |
88 | Ventricular tachycardia (HP:0004756) | 1.67370828 |
89 | Long clavicles (HP:0000890) | 1.64654879 |
90 | * Metatarsus adductus (HP:0001840) | 1.62279316 |
91 | Short palpebral fissure (HP:0012745) | 1.61938398 |
92 | Abnormal atrioventricular conduction (HP:0005150) | 1.61336630 |
93 | Increased density of long bones (HP:0006392) | 1.60787713 |
94 | Type 2 muscle fiber atrophy (HP:0003554) | 1.60346747 |
95 | Easy fatigability (HP:0003388) | 1.58566642 |
96 | Exercise intolerance (HP:0003546) | 1.56576321 |
97 | Congenital hip dislocation (HP:0001374) | 1.54752853 |
98 | Cholelithiasis (HP:0001081) | 1.54339098 |
99 | Stridor (HP:0010307) | 1.53934375 |
100 | Abnormality of potassium homeostasis (HP:0011042) | 1.51947169 |
101 | Lower limb amyotrophy (HP:0007210) | 1.51347861 |
102 | Increased purine levels (HP:0004368) | 1.49612019 |
103 | Hyperuricemia (HP:0002149) | 1.49612019 |
104 | Ventricular arrhythmia (HP:0004308) | 1.45886611 |
105 | Muscle fiber atrophy (HP:0100295) | 1.44497376 |
106 | Mesomelia (HP:0003027) | 1.44349473 |
107 | Ragged-red muscle fibers (HP:0003200) | 1.42363979 |
108 | Gout (HP:0001997) | 1.41864667 |
109 | Thin ribs (HP:0000883) | 1.41455857 |
110 | Lipoatrophy (HP:0100578) | 1.40787189 |
111 | Dilated cardiomyopathy (HP:0001644) | 1.40341199 |
112 | Foot dorsiflexor weakness (HP:0009027) | 1.40058324 |
113 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.39286983 |
114 | Fibular aplasia (HP:0002990) | 1.38807333 |
115 | Oligomenorrhea (HP:0000876) | 1.37684621 |
116 | * Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.36441714 |
117 | Wrist flexion contracture (HP:0001239) | 1.36182476 |
118 | Steppage gait (HP:0003376) | 1.33011347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 8.66198386 |
2 | TTN | 6.15438536 |
3 | PHKG1 | 5.46307855 |
4 | PHKG2 | 5.46307855 |
5 | NME1 | 4.37040554 |
6 | PIK3CG | 4.19537042 |
7 | MAP2K3 | 2.90537260 |
8 | NEK1 | 2.29350447 |
9 | TRIB3 | 2.16344312 |
10 | MAP3K7 | 2.12872920 |
11 | PINK1 | 1.98342729 |
12 | PDK3 | 1.77778247 |
13 | PDK4 | 1.77778247 |
14 | PIK3CA | 1.70735222 |
15 | DMPK | 1.67704295 |
16 | MAPK12 | 1.64406020 |
17 | MUSK | 1.61235226 |
18 | MAP2K4 | 1.59833112 |
19 | MAP2K6 | 1.43605445 |
20 | BCKDK | 1.32629824 |
21 | PDK2 | 1.17551825 |
22 | MAPKAPK3 | 1.07364565 |
23 | MAP3K3 | 0.98218118 |
24 | MARK1 | 0.90286551 |
25 | NEK9 | 0.87660582 |
26 | PRKAA2 | 0.85332745 |
27 | PRKAA1 | 0.79479752 |
28 | TRPM7 | 0.75109617 |
29 | STK24 | 0.72550468 |
30 | TAOK2 | 0.72545019 |
31 | ERBB3 | 0.71185301 |
32 | MAP3K13 | 0.69681975 |
33 | AKT2 | 0.63959414 |
34 | SIK1 | 0.62951756 |
35 | MAPK11 | 0.62690633 |
36 | PKN2 | 0.62133813 |
37 | EPHB1 | 0.62120776 |
38 | CAMK2G | 0.58110311 |
39 | MAP3K11 | 0.57487782 |
40 | ZAK | 0.57197122 |
41 | TAOK1 | 0.57132670 |
42 | RIPK1 | 0.52960671 |
43 | ILK | 0.51674000 |
44 | CAMK4 | 0.51669801 |
45 | LIMK1 | 0.49952944 |
46 | PTK6 | 0.46218945 |
47 | EEF2K | 0.44221469 |
48 | CAMK2A | 0.39745535 |
49 | CAMK2B | 0.36120673 |
50 | CAMK1 | 0.35712467 |
51 | MOS | 0.34443552 |
52 | SGK1 | 0.34131988 |
53 | MAP3K6 | 0.31458722 |
54 | MAP3K5 | 0.31215672 |
55 | MAP3K10 | 0.30902695 |
56 | KSR2 | 0.30446752 |
57 | MAP2K1 | 0.29377932 |
58 | PRKG1 | 0.28975734 |
59 | MAPK13 | 0.27413588 |
60 | LATS1 | 0.27245217 |
61 | TBK1 | 0.27222484 |
62 | RPS6KB1 | 0.26855822 |
63 | MAP3K1 | 0.26811773 |
64 | SGK2 | 0.25742013 |
65 | PRKACB | 0.25596480 |
66 | ARAF | 0.25391109 |
67 | CDK19 | 0.25128113 |
68 | PKN1 | 0.25062307 |
69 | RPS6KA3 | 0.24540972 |
70 | MARK2 | 0.24230509 |
71 | ROCK1 | 0.22847799 |
72 | ERN1 | 0.22213782 |
73 | MAPK7 | 0.21192466 |
74 | MAPK4 | 0.20543760 |
75 | PRKACA | 0.18148020 |
76 | PRPF4B | 0.16810660 |
77 | PDPK1 | 0.16799622 |
78 | LRRK2 | 0.16156578 |
79 | PRKD1 | 0.15728308 |
80 | CAMK1G | 0.15334459 |
81 | LATS2 | 0.15063669 |
82 | TGFBR2 | 0.14892334 |
83 | DYRK1B | 0.13806787 |
84 | FER | 0.13660364 |
85 | TYK2 | 0.13621223 |
86 | MST1R | 0.13482915 |
87 | TIE1 | 0.13460130 |
88 | DAPK2 | 0.12575854 |
89 | RPS6KL1 | 0.11834964 |
90 | RPS6KC1 | 0.11834964 |
91 | PDK1 | 0.11719226 |
92 | RAF1 | 0.11222269 |
93 | INSRR | 0.11174595 |
94 | PAK6 | 0.10395819 |
95 | DDR2 | 0.10384719 |
96 | ZAP70 | 0.09582729 |
97 | BMX | 0.09523379 |
98 | FGFR1 | 0.09222520 |
99 | MAP2K2 | 0.08997317 |
100 | RPS6KA1 | 0.08390839 |
101 | SGK223 | 0.07626137 |
102 | SGK494 | 0.07626137 |
103 | RPS6KA6 | 0.07498037 |
104 | RPS6KB2 | 0.07186576 |
105 | ICK | 0.06669987 |
106 | MTOR | 0.06516065 |
107 | ROCK2 | 0.06219397 |
108 | CDC42BPA | 0.05929014 |
109 | RPS6KA2 | 0.05885567 |
110 | NLK | 0.04896825 |
111 | GSK3A | 0.03833872 |
112 | MAPK10 | 0.03695039 |
113 | PRKACG | 0.03252685 |
114 | EPHA3 | 0.03156469 |
115 | JAK2 | 0.03019745 |
116 | TNK2 | 0.03003752 |
117 | PRKG2 | 0.02899170 |
118 | CAMK2D | 0.02890286 |
119 | BRAF | 0.02727004 |
120 | CSNK1D | 0.02595096 |
121 | SGK3 | 0.02249816 |
122 | MAPK8 | 0.02114209 |
123 | PTK2B | 0.01890693 |
124 | FGFR3 | 0.01493861 |
125 | PDGFRA | 0.01250782 |
126 | RET | 0.00517282 |
127 | STK11 | 0.00367321 |
128 | CDK6 | -0.0230890 |
129 | CCNB1 | -0.0199042 |
130 | KSR1 | -0.0180499 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.42721441 |
2 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.97142557 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.88981867 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.60657262 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.56204530 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.05396286 |
7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.99736011 |
8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.39827969 |
9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.36399191 |
10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.35863489 |
11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.34667944 |
12 | Insulin resistance_Homo sapiens_hsa04931 | 2.15950953 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10404185 |
14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.08962291 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01897961 |
16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.84047155 |
17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83979893 |
18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.83116323 |
19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.73983080 |
20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72792195 |
21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.70165965 |
22 | Tight junction_Homo sapiens_hsa04530 | 1.56173562 |
23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51031305 |
24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50385224 |
25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46879556 |
26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44928751 |
27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41524514 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38746489 |
29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.37793142 |
30 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.36111547 |
31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27464160 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24771297 |
33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23826720 |
34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21301132 |
35 | Focal adhesion_Homo sapiens_hsa04510 | 1.21226175 |
36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15897046 |
37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12183831 |
38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12053335 |
39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09361245 |
40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08858084 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05105092 |
42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98263164 |
43 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96542652 |
44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91510253 |
45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88710831 |
46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86989431 |
47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82422611 |
48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81893493 |
49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79854954 |
50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77588711 |
51 | Renin secretion_Homo sapiens_hsa04924 | 0.73257982 |
52 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71768473 |
53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71291996 |
54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66257532 |
55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65260733 |
56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64114821 |
57 | Platelet activation_Homo sapiens_hsa04611 | 0.63173445 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58842898 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58732811 |
60 | Amoebiasis_Homo sapiens_hsa05146 | 0.56099045 |
61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55443411 |
62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53969448 |
63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52920090 |
64 | Insulin secretion_Homo sapiens_hsa04911 | 0.52363226 |
65 | Adherens junction_Homo sapiens_hsa04520 | 0.52153722 |
66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45433586 |
67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42032513 |
68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40151745 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37228290 |
70 | Long-term depression_Homo sapiens_hsa04730 | 0.36082854 |
71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34410147 |
72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34129377 |
73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33542526 |
74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32495785 |
75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31756123 |
76 | Phototransduction_Homo sapiens_hsa04744 | 0.31344233 |
77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29806425 |
78 | Lysine degradation_Homo sapiens_hsa00310 | 0.29175607 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27837218 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27798449 |
81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27770549 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24955998 |
83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24921906 |
84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24108792 |
85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23943696 |
86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22357667 |
87 | Peroxisome_Homo sapiens_hsa04146 | 0.21927846 |
88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.21460731 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19967167 |
90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19300873 |
91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18621774 |
92 | Melanogenesis_Homo sapiens_hsa04916 | 0.18347460 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.17926664 |
94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17402200 |
95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17115907 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16966518 |
97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16618893 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15014650 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14394167 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13744142 |
101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13452625 |
102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12661566 |
103 | Salivary secretion_Homo sapiens_hsa04970 | 0.12361884 |
104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12290949 |
105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.12278525 |
106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.10288474 |
107 | Bile secretion_Homo sapiens_hsa04976 | 0.10250595 |
108 | Glioma_Homo sapiens_hsa05214 | 0.09618540 |
109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09554842 |
110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.09216996 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09061794 |
112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.08739301 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06344749 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03030189 |
115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.02940312 |
116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02595513 |